Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2025-12-24 @ 3:35 PM
NCT ID:
NCT00440492
Brief Summary:
The purpose of this study is to determine if PLA-695 changes the blood concentrations of methotrexate when administered together.
Study:
NCT00440492
Study Brief:
Protocol Section:
NCT00440492